SOPHiA GENETICS S.A.
SOPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $19 | $18 | $18 | $18 |
| % Growth | 6.2% | 3.1% | 0.3% | – |
| Cost of Goods Sold | $7 | $6 | $6 | $6 |
| Gross Profit | $13 | $12 | $12 | $12 |
| % Margin | 66.3% | 67% | 68.7% | 68.2% |
| R&D Expenses | $9 | $8 | $9 | $9 |
| G&A Expenses | $14 | $12 | $12 | $13 |
| SG&A Expenses | $23 | $22 | $19 | $21 |
| Sales & Mktg Exp. | $9 | $10 | $8 | $8 |
| Other Operating Expenses | -$1 | $0 | -$0 | -$0 |
| Operating Expenses | $31 | $31 | $28 | $30 |
| Operating Income | -$18 | -$19 | -$16 | -$17 |
| % Margin | -91.8% | -101.3% | -90.2% | -98.4% |
| Other Income/Exp. Net | -$2 | -$3 | -$1 | $3 |
| Pre-Tax Income | -$19 | -$22 | -$17 | -$15 |
| Tax Expense | $1 | $1 | $1 | $1 |
| Net Income | -$20 | -$22 | -$17 | -$15 |
| % Margin | -102.9% | -122.3% | -97.8% | -85.5% |
| EPS | -0.3 | -0.33 | -0.26 | -0.23 |
| % Growth | 9.1% | -26.9% | -13% | – |
| EPS Diluted | -0.3 | -0.33 | -0.26 | -0.23 |
| Weighted Avg Shares Out | 68 | 67 | 67 | 66 |
| Weighted Avg Shares Out Dil | 68 | 67 | 67 | 66 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $1 | $2 | $2 | $2 |
| EBITDA | -$17 | -$19 | -$14 | -$8 |
| % Margin | -88.6% | -102.2% | -78.3% | -44.8% |